Beam Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference

Company Overview - Beam Therapeutics Inc. is a biotechnology company focused on developing precision genetic medicines through base editing [3] - The company aims to establish a leading, fully integrated platform for precision genetic medicines, incorporating gene editing, delivery, and internal manufacturing capabilities [3] - Beam's proprietary base editing technology allows for precise, predictable, and efficient single base changes in targeted genomic sequences without causing double-stranded breaks in DNA [3] Upcoming Event - John Evans, the CEO of Beam Therapeutics, will present at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026, at 5:15 p.m. PT in San Francisco [1] - The live webcast of the presentation will be available on the company's investor section of the website and archived for 60 days [2]